Fibromyalgia Diagnosis Gets New Guidelines—But Challenges Remain

Fibromyalgia is a long-term condition marked by widespread pain, tenderness, and fatigue. Diagnosing it remains difficult because no single test can confirm the illness. Patients often wait years for a clear answer. The American College of Rheumatology now supports updated criteria for diagnosing fibromyalgia. Doctors evaluate a widespread pain index (WPI) and a symptom severity scale (SS) to assess the condition. A patient must meet three specific conditions under these guidelines to receive a diagnosis.

In the past, doctors relied on checking tender points across the body. While this method is no longer mandatory, some may still use it during an examination. The process also involves ruling out other possible conditions through careful assessment of symptoms.

The absence of definitive lab or imaging tests adds to the challenge. As a result, many patients face a long wait, with estimates suggesting an average of five years before a proper diagnosis is made. The new diagnostic approach focuses on the WPI and SS scores. Doctors still consider tender points in some cases, but the updated criteria aim to improve accuracy. Despite these changes, diagnosis remains complex and time-consuming for many.